Price
No data yet.
Social Signal Score
Analyst Ratings
7 analystsRevenue
$2.32MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Robert Goodman
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 54
- Beta
- 0.15
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -15.00
Financials
Revenue
$2.32M-69.9%Net Income
$-7.82MEBITDA
$-5.82MFree Cash Flow
$-6.32MEPS (diluted)
$-3.76Shares Outstanding (diluted)
2.08M+1336.5%Operating Expenses
$6.17MCash & Debt
$11.05MReturn of Capital
$0.00Revenue by Segment (annual)
$7.68MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $7.68M | $-33.25M | $-4.01 |
| 2025 | $3.71M | $-46.63M | $-275.40 |
| 2024 | $1.16M | $-60.24M | $-726.60 |
| 2023 | $0.00 | $-55.82M | $-744.80 |
| 2022 | $0.00 | $-43.18M | $-672.80 |
| 2021 | $873.0K | $-22.88M | $-508.20 |
| 2020 | $1.39M | $-19.94M | $-711.40 |
| 2019 | $7.72M | $-6.56M | $-308.69 |
| 2018 | $0.00 | $-18.04M | $-1204.00 |
| 2016 | $0.00 | $-29.7K | $-0.21 |
| 2017 | $0.00 | $-3.72M | $-25.70 |
| 2015 | $0.00 | $-4.81M | $-33.20 |
| 2014 | $0.00 | $-1.65M | $-11.40 |
Valuation
XAIRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+25.00%Social Signal Score
Mentions (9)
- Newsglobenewswire.com·20d ago·Neutral
Max Hospitality Selects Beyond Oil as Frying Standard Across Its Restaurants and Venues Hartford-based group of chef-driven restaurants and catering serving Connecticut and Massachusetts since 1986, endorses Beyond Oil's frying technology Hartford-based group of chef-driven restaurants and catering serving Connecticut and Massachusetts since 1986, endorses Beyond Oil's frying technology
View source ↗ - Newsglobenewswire.com·24d ago·Neutral
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2026 GARDEN CITY, N.Y., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended September 30, 2026 on Wednesday, November 11, 2026.
View source ↗ - Newsglobenewswire.com·27d ago·Neutral
Beyond Oil Announces First Commercial Adoption in the Industrial Frying Segment Industrial food-production facility adopts Beyond Oil as part of its standard frying operations, marking the Company's first commercial adoption in the industrial-frying segment Industrial food-production facility adopts Beyond Oil as part of its standard frying operations, marking the Company's first commercial adoption in the industrial-frying segment
View source ↗ - Newsglobenewswire.com·32d ago·Negative
Beyond Oil Enters the Romanian Market with Initial Order from New Distributor VANCOUVER, British Columbia, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (TSX: BOIL) (OTCQB: BEOLF) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks associated with fried food while improving food quality, lowering operational costs, minimizing waste and enhancing sustainability, today announced that it has entered the Romanian market through a new distribution ar
View source ↗ - Newsglobenewswire.com·34d ago·Neutral
Duchess Restaurants Selects Beyond Oil as Frying Standard Across the Chain Homegrown Connecticut quick-service restaurant chain, serving diners since 1956, endorses Beyond Oil's frying technology Homegrown Connecticut quick-service restaurant chain, serving diners since 1956, endorses Beyond Oil's frying technology
View source ↗ - Newsglobenewswire.com·40d ago·Negative
Beyond Oil Appoints Joe Colligan as Chief Executive Officer of Beyond Oil USA Commercial leader brings more than 30 years of experience at McCain Foods, Unilever and OSI Group Will work to accelerate North American expansion of Beyond Oil's solution for safer, better and more profitable frying VANCOUVER, British Columbia, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (TSX: BOIL) (OTCQB: BEOLF) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks
View source ↗ - Newsglobenewswire.com·83d ago·Negative
…ation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to LungFit GO for the treatment of nontub…
View source ↗ - Newsglobenewswire.com·89d ago·Negative
…igible to receive up to $32.5 million in development and commercial milestone payments GARDEN CITY, N.Y., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) today announced that they have entered into a definitive agreement under which UNIVO Pharmaceutical Industries Ltd (“UNIVO”) Univo Pharmaceutical Industries Ltd.
View source ↗ - Newsseekingalpha.com·101d ago·Positive
Beyond Air, Inc. (XAIR) Q1 2027 Earnings Call Transcript Beyond Air, Inc. (XAIR) Q1 2027 Earnings Call Transcript
View source ↗
Earnings
Thu, Feb 11(in 3 months)
Consensus estimate $-2.17 per share
Typical surprise -13.3% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 11$-3.76 vs $-3.31miss
- Thu, Aug 13$-11.00 vs $-10.80miss
- Fri, Jun 26$-15.40 vs $-11.33miss
- Fri, Feb 13$-17.00 vs $-15.01miss
- Mon, Nov 10$-25.00 vs $-15.47miss
- Tue, Aug 12$-30.60 vs $-30.00miss
Estimates and results for XAIR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by XAIR officers and directors.
- Bought
- $990k
- Sold
- —
14 trades
0 trades
- Lin Yi-chienbought
- Lin Yi-chienbought
- Lin Yi-chienbought
- Lin Yi-chienbought
- Goodman Robert Scottbought
- Goodman Robert Scottbought
- Goodman Robert Scottbought
- Moorhead Daniel Jbought
86 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in XAIR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
